BeStock  
Stocks › Biotechnology › COGT

Cogent Biosciences COGT

US equityMarket cap rank #2102Biotechnology
$26.72 −$1.03 (-3.70%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.20 +1.82%
Open$27.26
Prev close$27.74
Day range$26.62 – $27.83
Volume2.13M
Market cap$4.65B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-12.6x
CheapRich

Below its usual level · 20th percentile, 5-year average -6.6x

Price / book11.0x
CheapRich

Above its usual level · 79th percentile, 5-year average 8.4x

#4982 of 5331 stocks by PB (1 = cheapest)

P/E over five years

-21x-14x-6x1xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$36.59
Price vs. fair value-27.0%Trading below the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 11.01 – 8.39 79% (pricier than usual) #4982 of 5331 (1 = cheapest)
PE -12.64 -16.49 -6.59 20% (cheaper than usual) –
PS – 29.88 114.18 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on COGT.

Sign in to join the discussion.

Scroll to Top